[Cardiac-pulmonary effects of aldactone in chronic cor pulmonale].
D000136:Acid-Base Equilibrium; D000368:Aged; D001784:Blood Gas Analysis; D001794:Blood Pressure / Q000187:drug effects; D001991:Bronchitis / Q000503:physiopathology; D002302:Cardiac Output / Q000187:drug effects; D002908:Chronic Disease; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007275:Injections, Intravenous; D008173:Lung Diseases, Obstructive / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011651:Pulmonary Artery; D011656:Pulmonary Emphysema / Q000503:physiopathology; D011660:Pulmonary Heart Disease / Q000188:drug therapy / Q000503:physiopathology*; D012119:Respiration / Q000187:drug effects*; D013148:Spironolactone / Q000494:pharmacology* / Q000627:therapeutic use
D013148:Spironolactone
Die Wirkung von Aldactone auf Atmung und Lungenkreislauf beim chronischen Cor pulmonale.